检索范围:
排序: 展示方式:
Mechanism of vascular endothelial growth factor on the prevention of restenosis after angioplasty
Qigong LIU, Honglian ZHOU, Yan ZENG, Shan YE, Jiani LIU, Zaiying LU
《医学前沿(英文)》 2009年 第3卷 第2期 页码 177-180 doi: 10.1007/s11684-009-0021-x
关键词: vascular endothelial growth factors restenosis reactive oxygen species endothelial cells vascular smooth muscle cell
Role of nitric oxide in biological effects of vascular endothelial growth factor
Qigong LIU M D , Yan ZENG , Jiani LIU , Shan YE , Yongdong LI , Zaiying LU M D ,
《医学前沿(英文)》 2009年 第3卷 第3期 页码 284-286 doi: 10.1007/s11684-009-0062-1
关键词: vascular endothelial growth factor nitric oxide N-nitro-L-arginine methyl ester vascular endothelial cells
糖尿病发作后心脏脂蛋白脂肪酶的变化 Review
Chae Syng Lee, Yajie Zhai, Brian Rodrigues
《工程(英文)》 2023年 第20卷 第1期 页码 19-25 doi: 10.1016/j.eng.2022.06.013
由于心脏持续地收缩和舒张,需要大量的能量,其中脂肪酸(FA)是其三磷酸腺苷(ATP)的主要来源。但是,心脏无法制造这种底物,而是从多种来源获得脂肪酸,包括通过脂蛋白脂肪酶(LPL)的作用。脂蛋白脂肪酶在心肌细胞中产生,随后分泌到质膜上的硫酸乙酰肝素蛋白聚糖(HSPG)结合位点。然后为了将脂蛋白脂肪酶转移到内皮细胞管腔,糖基磷脂酰肌醇锚定的高密度脂蛋白结合蛋白1(GPIHBP1)与间质性脂蛋白脂肪酶结合,并将其转移到血管管腔,在那里脂蛋白脂肪酶可将循环中的甘油三酯分解为脂肪酸。内源性-β-葡萄糖醛酸酶乙酰肝素酶(Hpa)的独特之处在于,它是唯一已知的哺乳动物酶,可以裂解硫酸乙酰肝素,从而促进上述脂蛋白脂肪酶从心肌细胞HSPG中释放。在糖尿病中,一直认为心脏产生能量方式的改变是导致糖尿病性心肌病(DCM)的原因。糖尿病发展到中度后,随着葡萄糖利用率的降低,由于Hpa 作用的增强,心脏血管腔内的脂蛋白脂肪酶活性得到增强。虽然这种适应可能有助于补偿心脏对葡萄糖的利用不足,但从长期来看,它是具有毒性的,因为有害的脂质代谢物积聚,以及脂肪酸氧化增强和因此造成的氧化应激,最终导致细胞死亡。这与一种心脏保护生长因子——血管内皮生长因子B(VEGFB)的丧失同时发生。本文探讨了乙酰肝素酶、脂蛋白脂肪酶和血管内皮生长因子B之间的相互联系及其在糖尿病性心肌病中的潜在影响。鉴于缺乏基于机制的DCM治疗,了解这种心肌病的病理,以及脂蛋白脂肪酶的作用,将有助于我们推进其临床治疗。
Economic Growth Model Based on Six Basic Factors of Production—Xu Growth Rate Equation
Shou-bo Xu,Zong-yuan Huang
《工程管理前沿(英文)》 2014年 第1卷 第2期 页码 160-175 doi: 10.15302/J-FEM-2014024
关键词: six basic factors of production economic growth model Xu Growth Rate Equation
null
《医学前沿(英文)》 2012年 第6卷 第1期 页码 22-34 doi: 10.1007/s11684-012-0178-6
Stroke is a personal, familial, and social disaster. It is the third cause of death worldwide, the first cause of acquired disability, the second cause of dementia, and its cost is astronomic. The burden of stroke is likely to increase given the aging of the population and the growing incidence of many vascular risk factors. Prevention of stroke includes—as for all other diseases—a “mass approach” aiming at decreasing the risk at the society level and an individual approach, aiming at reducing the risk in a given subject. The mass approach is primarily based on the identification and treatment of vascular risk factors and, if possible, in the implementation of protective factors. These measures are the basis of primary prevention but most of them have now been shown to be also effective in secondary prevention. The individual approach combines a vascular risk factor modification and various treatments addressing the specific subtypes of stroke, such as antiplatelet drugs for the prevention of cerebral infarction in large and small artery diseases of the brain, carotid endarterectomy or stenting for tight carotid artery stenosis, and oral anticoagulants for the prevention of cardiac emboli. There is a growing awareness of the huge evidence-to-practice gap that exists in stroke prevention largely due to socio-economic factors. Recent approaches include low cost intervention packages to reduce blood pressure and cheap “polypills” combining in a single tablet aspirin and several drugs to lower blood pressure and cholesterol. Polypill intake should however not lead to abandon the healthy life-style measures which remain the mainstay of stroke prevention.
关键词: stroke prevention vascular risk factors cerebral infarction cerebral hemorrhage anti-thrombotic drugs carotid endarterectomy
Lihui WANG, Lianhong LI, Shen LV, Shujun FAN, Li ZHAN, Bo WANG, Zhong ZHANG
《医学前沿(英文)》 2009年 第3卷 第2期 页码 164-170 doi: 10.1007/s11684-009-0038-1
关键词: epithelial-mesenchymal transition vascular endothelial cell growth factor matrix metalloproteinase-9 cyclooxygenase-2 higher microvascular density breast cancer
Effects of resistin on insulin signaling in endothelial cells
Zhizhen LI, Fangping LI, Jianhong YE, Li YAN, Zuzhi FU
《医学前沿(英文)》 2009年 第3卷 第2期 页码 136-140 doi: 10.1007/s11684-009-0029-2
关键词: resistin endothelium nitric oxide endothelial nitric oxide synthase Akt-binding protein mouse
ZHANG Xiongfu, WANG Jinqu, LIU Hai′ou, WANG Anjie
《化学科学与工程前沿(英文)》 2007年 第1卷 第2期 页码 172-177 doi: 10.1007/s11705-007-0032-6
Emerging roles of podoplanin in vascular development and homeostasis
null
《医学前沿(英文)》 2015年 第9卷 第4期 页码 421-430 doi: 10.1007/s11684-015-0424-9
Podoplanin (PDPN) is a mucin-type O-glycoprotein expressed in diverse cell types, such as lymphatic endothelial cells (LECs) in the vascular system and fibroblastic reticular cells (FRCs) in lymph nodes. PDPN on LECs or FRCs activates CLEC-2 in platelets, triggering platelet activation and/or aggregation through downstream signaling events, including activation of Syk kinase. This mechanism is required to initiate and maintain separation of blood and lymphatic vessels and to stabilize high endothelial venule integrity within lymph nodes. In the vascular system, normal expression of PDPN at the LEC surface requires transcriptional activation of Pdpn by Prox1 and modification of PDPN with core 1-derived O-glycans. This review provides a comprehensive overview of the roles of PDPN in vascular development and lymphoid organ maintenance and discusses the mechanisms that regulate PDPN expression related to its function.
关键词: podoplanin CLEC-2 Prox1 O-glycosylation lymphatic vascular development and maintenance lymphoid organ homeostasis
Effect of hyperlipidemia on endothelial VCAM-1 expression and the protective role of fenofibrate
WU Jun, LIN Jinchao, HE Zhaochu, OU Biru, GUO Haisen
《医学前沿(英文)》 2007年 第1卷 第4期 页码 356-358 doi: 10.1007/s11684-007-0068-5
关键词: endothelial 16-week treatment leukocyte accumulation mg/kg NO
Weijian Hang, Chen Chen, Xin A. Zhang, Dao Wen Wang
《医学前沿(英文)》 2021年 第15卷 第4期 页码 638-643 doi: 10.1007/s11684-021-0831-z
关键词: COVID-19 endothelial dysfunction inflammation reaction cytokine storm
Crk-associated substrate, vascular smooth muscle and hypertension
TANG Dale
《医学前沿(英文)》 2008年 第2卷 第4期 页码 323-331 doi: 10.1007/s11684-008-0062-6
关键词: Contraction stimulation phosphatase-proline molecular structure discovered hypertension
Study on the action of resistin-induced human umbilical vein endothelial cell dysfunction
LI Zhizhen, LI Fangping, YAN Li, LI Feng, LI Yan, CHENG Hua, FU Zuzhi
《医学前沿(英文)》 2007年 第1卷 第2期 页码 196-199 doi: 10.1007/s11684-007-0037-z
关键词: endothelial resistin stimulation Incubation pathogenesis dysfunction
lncR-GAS5 upregulates the splicing factor to impair endothelial autophagy, leading to atherogenesis
《医学前沿(英文)》 2023年 第17卷 第2期 页码 317-329 doi: 10.1007/s11684-022-0931-4
关键词: lncR-GAS5 miR-193-5p splicing factor SRSF10 autophagy atherogenesis
Progress in tumor vascular normalization for anticancer therapy: challenges and perspectives
null
《医学前沿(英文)》 2012年 第6卷 第1期 页码 67-78 doi: 10.1007/s11684-012-0176-8
Antitumor angiogenic therapy has been shown promising in the treatment of several advanced cancers since the approval of the first antiangiogenic drug Avastin in 2004. Although the current antiangiogenic drugs reduce the density of tumor blood vessels and result in tumor shrinkage at the early stage of treatment, recent studies have shown that antiangiogenic therapy has transient and insufficient efficacy, resulting in tumor recurrence in patients after several months of treatment. Blockage of blood and oxygen supplies creates a hypoxic and acidic microenvironment in the tumor tissues, which fosters tumor cells to become more aggressive and metastatic. In 2001, Jain proposed tumor vascular normalization as an alternative approach to treating cancers based on the pioneering work on tumor blood vessels by several other researchers. At present, normalizing the disorganized tumor vasculature, rather than disrupting or blocking them, has emerged as a new option for anticancer therapy. Preclinical and clinical data have shown that tumor vascular normalization using monoclonal antibodies, proteins, peptides, small molecules, and pericytes resulted in decreased tumor size and reduced metastasis. However, current tumor vascular normalizing drugs display moderate anticancer efficacy. Accumulated data have shown that a variety of vasculogenic/angiogenic tumor cells and genes play important roles in tumor neovascularization, growth, and metastasis. Therefore, multiple-targeting of vasculogenic tumor cells and genes may improve the efficacy of tumor vascular normalization. To this end, the combination of antiangiogenic drugs with tumor vascular normalizing therapeutics, as well as the integration of Western medicine with traditional Chinese medicine, may provide a good opportunity for discovering novel tumor vascular normalizing drugs for an effective anticancer therapy.
关键词: angiogenesis vasculogenesis neovascularization tumor vasculature normalization traditional Chinese medicine
标题 作者 时间 类型 操作
Mechanism of vascular endothelial growth factor on the prevention of restenosis after angioplasty
Qigong LIU, Honglian ZHOU, Yan ZENG, Shan YE, Jiani LIU, Zaiying LU
期刊论文
Role of nitric oxide in biological effects of vascular endothelial growth factor
Qigong LIU M D , Yan ZENG , Jiani LIU , Shan YE , Yongdong LI , Zaiying LU M D ,
期刊论文
Economic Growth Model Based on Six Basic Factors of Production—Xu Growth Rate Equation
Shou-bo Xu,Zong-yuan Huang
期刊论文
Lymphatic metastasis is related to the epithelial-mesenchymal transition and expressions of VEGF, MMP-9, and COX-2 in breast cancer
Lihui WANG, Lianhong LI, Shen LV, Shujun FAN, Li ZHAN, Bo WANG, Zhong ZHANG
期刊论文
Effects of resistin on insulin signaling in endothelial cells
Zhizhen LI, Fangping LI, Jianhong YE, Li YAN, Zuzhi FU
期刊论文
Factors affecting the formation of zeolite seed layers and the effects of seed layers on the growth of
ZHANG Xiongfu, WANG Jinqu, LIU Hai′ou, WANG Anjie
期刊论文
Effect of hyperlipidemia on endothelial VCAM-1 expression and the protective role of fenofibrate
WU Jun, LIN Jinchao, HE Zhaochu, OU Biru, GUO Haisen
期刊论文
Endothelial dysfunction in COVID-19 calls for immediate attention: the emerging roles of the endothelium
Weijian Hang, Chen Chen, Xin A. Zhang, Dao Wen Wang
期刊论文
Study on the action of resistin-induced human umbilical vein endothelial cell dysfunction
LI Zhizhen, LI Fangping, YAN Li, LI Feng, LI Yan, CHENG Hua, FU Zuzhi
期刊论文
lncR-GAS5 upregulates the splicing factor to impair endothelial autophagy, leading to atherogenesis
期刊论文